FIELD: medicine.
SUBSTANCE: offered means is applied for anaemia prevention and treatment within neurotic states. Such is adrenoceptor antagonists application. It is proved, that introduced adrenoceptor antagonists dihydroergo-thamin or propranolol for narcolepsy depivation provide cancellation of bone-marrow erythropoiesis depression and normalise erythroid blood content.
EFFECT: means has improved efficiency.
5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR STUDYING HEMOPOIESIS WITH INDIVIDUAL HIGHER NERVOUS ACTIVITY SPECIFIC BEING TAKEN INTO ACCOUNT | 2006 |
|
RU2317541C1 |
| MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
| METHOD FOR CONTROLLING ERYTHROPOIESIS DISORDERS IN EXPERIMENTAL ENCEPHALOPATHY CASES | 2005 |
|
RU2302664C2 |
| METHOD FOR CORRECTING AFFECTED ERYTHROPOIESIS AT EXPERIMENTAL HYPOXIA | 2005 |
|
RU2285300C1 |
| METHOD OF BLOOD SYSTEM DISTURBANCE THERAPY ASSOCIATED WITH EXPERIMENTAL NEUROTIC AFFECTS | 2006 |
|
RU2329806C2 |
| MEANS FOR CORRECTION OF VIOLATIONS IN HEMOGENESIS ERYTHROID LINEAGE CAUSED BY CYSTOSTATIC IMPACT | 2016 |
|
RU2634572C1 |
| METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
| METHOD FOR COMBINED TREATMENT FOR ASIDEROTIC ANEMIA | 2007 |
|
RU2331412C1 |
| METHOD FOR DIVIDING INBRED MICE INTO TYPOLOGICAL GROUPS WITH HIGHER NERVOUS ACTIVITY SPECIFICITY TAKEN INTO CONSIDERATION | 2006 |
|
RU2316057C1 |
| MEDICATION PREVENTING DEVELOPMENT OF DEPRESSION OF HEMATOPOIESIS ERYTHROID LINEAGE IN CASE OF CYTOSTATIC MYELO DEPRESSIONS | 2007 |
|
RU2351333C1 |
